CN1322558A - Liver cancer resisting medicine - Google Patents

Liver cancer resisting medicine Download PDF

Info

Publication number
CN1322558A
CN1322558A CN01114204A CN01114204A CN1322558A CN 1322558 A CN1322558 A CN 1322558A CN 01114204 A CN01114204 A CN 01114204A CN 01114204 A CN01114204 A CN 01114204A CN 1322558 A CN1322558 A CN 1322558A
Authority
CN
China
Prior art keywords
parts
radix
rhizoma
portions
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN01114204A
Other languages
Chinese (zh)
Other versions
CN1164294C (en
Inventor
潘志明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pan Wencheng
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011142049A priority Critical patent/CN1164294C/en
Publication of CN1322558A publication Critical patent/CN1322558A/en
Application granted granted Critical
Publication of CN1164294C publication Critical patent/CN1164294C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The liver cancer resisting medicine is prepared with 34 kinds of Chinese medicinal plant and animal materials including Herba Hedyotis Diffusae, sun plant, Lobelia chinensis, Rhizoma Paridis, scorpion, etc. And decoction and concentration. The medicine of the present invention can liquefy, reduce and eliminate liver tumor and restore damaged liver part without damaging health cells of body.

Description

A kind of anti-liver cancer drug
The present invention relates to a kind of Chinese herbal medicine, especially a kind of anti-liver cancer drug.
Cancer is one of pertinacious disease that is difficult to cure most in the world at present.Depend on operation at the western medical treatment liver cancer at present, radiotherapy, chemotherapy, patient is painful unusually, comes off with healthy hair.In therapeutic process, the human normal cell comes to harm too in the time of kill cancer cell, and medical expense is high.The traditional Chinese medical science in most cases can only be controlled for the treatment liver tumor, haveing breakthrough aspect the life quality that improves patient, but still fully can not healing person.
The purpose of this invention is to provide and a kind ofly can make liver tumor liquefaction, dwindle and even disappear, and don't injure the human normal cell, allow most patients can rehabilitation, the medicines resistant to liver cancer of existence.
The present invention adopts Chinese herbal medicine and animal kind medicine to make.
The material component proportioning is:
10~50 parts of 10~50 portions of Herba Lobeliae Chinensis of 10~15 portions of Herba Scutellariae Barbataes of Herba Hedyotidis Diffusae
10~30 parts of 10~50 parts of rhizoma sparganic of 10~30 parts of Herba Patriniae of Paris polyphylla
10~50 parts of 10~30 parts of SEMEN COICIS of 10~30 parts of Rhizoma Arisaematiss of Rhizoma Curcumae
10~20 parts of 10~30 parts of Rhizoma Corydalis of 10~50 parts of Radix Bupleuri of Fructus Crataegi
10~30 parts of 10~30 parts of Myrrhas of 10~30 parts of Olibanums of Radix Salviae Miltiorrhizae
10~30 parts of 10~20 parts of Radix Ginsengs of 10~30 parts of Scolopendras of Scorpio
10~30 parts of Squama Maniss of the Rhizoma Atractylodis Macrocephalae are fried 10~40 parts of Carapax Trionycis for 10~50 parts
10~30 parts of 10~30 portions of Radix Paeoniae Albas of 10~30 parts of Radix Paeoniae Rubra of Radix Angelicae Sinensis
10~50 parts of 10~30 parts of Herba Hyperici Japonici of 10~30 parts of Fructus Aurantiis of the Radix Aucklandiae
10~30 parts of 10~50 portions of Rhizoma Cyperis of 10~20 portions of Radix Cirsii Japonicis of Radix Glycyrrhizae
10~30 parts of 10~50 parts of Fructus Lycii of 10~30 parts of Concha Ostreae of Radix Clematidis
10~50 parts of Fructus Trichosanthis roots (Radix Trichosanthis)
Production technology adopts water-boiling method, and promptly raw material adds water and soaked 10~30 minutes in 1: 7 ratio, and decocting boils once then, boils three hours at every turn, filter, concentrate, put cold, make oral liquid (adding medical antiseptic storage), finished product.Can make also that glue is assisted or dosage form such as pill.
The present invention adopts Chinese herbal medicine and part animal drugs to make through water-boiling method, taking convenience, medicine, raw material are formed rationally, have hard masses softening and resolving, the effect of blood circulation promoting and blood stasis dispelling, anti-malignant tumor, healing, slightly poisonous, take safety for a long time, have no side effect, the water-boiling method manufacturing condition easily satisfies, and is convenient to manipulation in the production process, be beneficial to the maintenance manufactured goods, steady quality.
The present invention can make hepatoma lump liquefaction, by toxin expelling, make lump dwindle, disappear, impaired part granulation promoting, recover normal, this hepatocarcinoma medicine oral liquid body normal cell of not hurting sb.'s feelings by taking treatment, can allow most patient's rehabilitations, maintenance life.
Elaborate below in conjunction with embodiment.
Example 1:
Take by weighing Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Herba Lobeliae Chinensis, Herba Patriniae, each 30 gram of Radix Trichosanthis; Fry Carapax Trionycis, each 35 gram of Radix Cirsii Japonici; Paris polyphylla, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Arisaematis, Radix Salviae Miltiorrhizae, the Rhizoma Atractylodis Macrocephalae, Squama Manis, Radix Paeoniae Rubra, Herba Hyperici Japonici, Rhizoma Cyperi, each 15 gram of Radix Clematidis; Radix Bupleuri, Rhizoma Corydalis, Olibanum, Myrrha, Scorpio, Radix Ginseng, Radix Angelicae Sinensis, the Radix Aucklandiae, Fructus Aurantii, Radix Glycyrrhizae, each 10 gram of Fructus Lycii; The Radix Paeoniae Alba 20 grams, Scolopendra 3 treaties 15 grams; SEMEN COICIS 50 gram, Fructus Crataegi 50 grams, Concha Ostreae 50 grams amount to 680 grams, add water in 1 to 7 ratio and soak 10 minutes for 5 kilograms, decocting boils then, slow fire boiled three hours, filter, concentrate, put cold, adding antiseptic, storage, pack finished product.
Example 2:
Take by weighing Herba Hedyotidis Diffusae 10 grams, Herba Scutellariae Barbatae 10 grams, Herba Lobeliae Chinensis 10 grams, Rhizoma Paridis (Paris polyphylla) 10 grams, Olibanum 10 grams, Myrrha 10 grams, Squama Manis 30 grams, Scorpio 10 grams, Scolopendra 10 grams, Concha Ostreae 30 grams, Radix Glycyrrhizae 10 grams, the Radix Paeoniae Alba 15 grams, Herba Patriniae 15 grams, rhizoma sparganic 10 grams, Rhizoma Curcumae 10 grams, Rhizoma Cyperi 10 grams, Fructus Aurantii 10 grams, Radix Bupleuri 10 grams, the Radix Aucklandiae 10 grams, Rhizoma Corydalis 10 grams, Radix Ginseng 10 grams, Radix Clematidis 10 grams, Radix Angelicae Sinensis 10 grams, Herba Hyperici Japonici 30 grams, Radix Trichosanthis 20 grams, Rhizoma Arisaematis 15 grams, Fructus Lycii 10 grams, Radix Paeoniae Rubra 10 grams, Radix Salviae Miltiorrhizae 15 grams, SEMEN COICIS 30 grams, Fructus Crataegi 20 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, fry Carapax Trionycis 30 grams, Radix Cirsii Japonici 35 grams amount to: 510 grams.
The ratio of raw material and water adds water with above crude drug 510 grams and soaked 30 minutes for 3.57 kilograms by 1: 7, and decocting boiled three hours then, medical filtration, concentrate, put cold, add medical antiseptic storage, pack finished product.
Anti-liver cancer drug oral liquid of the present invention shows that through the zoopery result of pharmacology teaching and research room of Guangxi Medical University tangible anticarcinogenesis (seeing Appendix) is arranged.
Clinical trial proves that this anti-liver cancer drug oral liquid is evident in efficacy for small liver cancer 2~3cm, lump dwindle to some extent or disappear (attached after the clinical efficacy data).

Claims (1)

1, a kind of anti-liver cancer drug is characterized in that the material component proportioning is:
10~50 parts of 10~50 portions of Herba Lobeliae Chinensis of 10~15 portions of Herba Scutellariae Barbataes of Herba Hedyotidis Diffusae
10~30 parts of 10~50 parts of rhizoma sparganic of 10~30 parts of Herba Patriniae of Paris polyphylla
10~50 parts of 10~30 parts of SEMEN COICIS of 10~30 parts of Rhizoma Arisaematiss of Rhizoma Curcumae
10~20 parts of 10~30 parts of Rhizoma Corydalis of 10~50 parts of Radix Bupleuri of Fructus Crataegi
10~30 parts of 10~30 parts of Myrrhas of 10~30 parts of Olibanums of Radix Salviae Miltiorrhizae
10~30 parts of 10~20 parts of Radix Ginsengs of 10~30 parts of Scolopendras of Scorpio
10~30 parts of Squama Maniss of the Rhizoma Atractylodis Macrocephalae are fried 10~40 parts of Carapax Trionycis for 10~50 parts
10~30 parts of 10~30 portions of Radix Paeoniae Albas of 10~30 parts of Radix Paeoniae Rubra of Radix Angelicae Sinensis
10~50 parts of 10~30 parts of Herba Hyperici Japonici of 10~30 parts of Fructus Aurantiis of the Radix Aucklandiae
10~30 parts of 10~50 portions of Rhizoma Cyperis of 10~20 portions of Radix Cirsii Japonicis of Radix Glycyrrhizae
10~30 parts of 10~50 parts of Fructus Lycii of 10~30 parts of Concha Ostreae of Radix Clematidis
10~50 parts of Fructus Trichosanthis roots
CNB011142049A 2001-05-14 2001-05-14 Liver cancer resisting medicine Expired - Fee Related CN1164294C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011142049A CN1164294C (en) 2001-05-14 2001-05-14 Liver cancer resisting medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011142049A CN1164294C (en) 2001-05-14 2001-05-14 Liver cancer resisting medicine

Publications (2)

Publication Number Publication Date
CN1322558A true CN1322558A (en) 2001-11-21
CN1164294C CN1164294C (en) 2004-09-01

Family

ID=4660873

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011142049A Expired - Fee Related CN1164294C (en) 2001-05-14 2001-05-14 Liver cancer resisting medicine

Country Status (1)

Country Link
CN (1) CN1164294C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100402078C (en) * 2003-11-18 2008-07-16 刘钦 Medicinal pills for clearing liver heat, dispelling toxic materials and promoting diuresis
CN103768534A (en) * 2014-02-17 2014-05-07 南京中医药大学 Traditional Chinese medicinal composition with anti-tumor activity
CN103830663A (en) * 2014-01-24 2014-06-04 何成元 A traditional Chinese medicine composition for treating liver cancer
CN105688147A (en) * 2016-02-27 2016-06-22 吴风平 Traditional Chinese medicine composition for treating tumors
CN112675269A (en) * 2021-01-09 2021-04-20 张继英 Anticancer and analgesic composition, preparation method and application thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100402078C (en) * 2003-11-18 2008-07-16 刘钦 Medicinal pills for clearing liver heat, dispelling toxic materials and promoting diuresis
CN103830663A (en) * 2014-01-24 2014-06-04 何成元 A traditional Chinese medicine composition for treating liver cancer
CN103768534A (en) * 2014-02-17 2014-05-07 南京中医药大学 Traditional Chinese medicinal composition with anti-tumor activity
CN105688147A (en) * 2016-02-27 2016-06-22 吴风平 Traditional Chinese medicine composition for treating tumors
CN112675269A (en) * 2021-01-09 2021-04-20 张继英 Anticancer and analgesic composition, preparation method and application thereof

Also Published As

Publication number Publication date
CN1164294C (en) 2004-09-01

Similar Documents

Publication Publication Date Title
CN1032622C (en) Medical liquid for relaxing tendons and joints
CN1814211A (en) Chinese herbal medicine decoction for treating acute icterohepatitis and preparing method
CN102210820A (en) Chinese medicinal composition for treating leukemia
CN1772196A (en) Heart failure regulating Chinese medicine
CN102161961A (en) Health-care wine and preparation method thereof
CN1931329A (en) Stomatocase treating medicine
CN102973840B (en) Chinese traditional medicine composite for curing acne
CN1164294C (en) Liver cancer resisting medicine
CN1077896A (en) Medicine for psoriasis and manufacture method
CN101336998B (en) Traditional Chinese medicine for treating whelk
CN1337246A (en) Chinese medicine for treating cerebral thrombus sequelae
CN1101199C (en) Chinese-medicinal capsule for treating hyperlipomia
CN1385191A (en) Medicine for treating liver disease
CN106491971A (en) A kind of for treating Chinese medicine composition of pulpitiss and preparation method thereof
CN102406765A (en) Traditional Chinese medicine composition for treating acne
CN1090183A (en) Artemisia scoparia and ginseng pellet for mourishing liver and method for production thereof
CN101549057A (en) Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
CN1931246A (en) Medicine for treating burns and scalds and its prepn process
CN1178682C (en) Angiocardiopathy treating traditional Chinese medicine
CN1919295A (en) Decoction medicine for treating stomatocace with heart heat syndrome and its preparation method
CN1059120C (en) Chinese medicine for treating bone wound
CN102727668A (en) Chinese medicine composition with effect of alleviating asthenopia and preparation method thereof
CN101584839A (en) Chinese medicament for treating acute and chronic cholecystitis
CN1772154A (en) Chinese herbal medicine decoction for treating premenstrual abdominal pain and its prepn
CN1857619A (en) Chinese medicine preparation for curing diabetes radically

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: PAN WENCHENG

Free format text: FORMER OWNER: PAN ZHIMING

Effective date: 20030829

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20030829

Address after: 530107, Guangxi County, Yuquan Township, Wuming Qing Feng Village 16 groups

Applicant after: Pan Wencheng

Address before: 530107 Yuquan Township Water Conservancy and water conservation station, Wuming County, Guangxi

Applicant before: Pan Zhiming

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040901

Termination date: 20110514